baber/WOPTO huggingface dataset:
Patent MX-2017008845-A (MX)
Title: Inspection device and method for inspecting an adhesive pattern on a substrate.
Inventor: ERIC LINGIER
IPC: B05D1/26
Filed: 2017-07-03
Abstract: Inspection devices and methods for inspecting an adhesive pattern on a substrate are disclosed. The inspection device includes at least one sensor having a heat sensor head for detecting a pattern of the adhesive bead, and a controller. Reference data representing a desired adhesive pattern is initially provided to a controller. A predetermined tolerance range for the desired adhesive pattern is also provided to the controller. An adhesive bead is discharged onto a substrate from a nozzle. A pattern of the discharged adhesive bead is then detected by the sensor when the substrate moves. Signals representing the detected pattern are received from the sensor at the controller. Finally, the signals representing the detected adhesive pattern are compared to the tolerance range of the desired adhesive pattern.
Patent MX-2017010553-A (MX)
Title: Retroviral and lentiviral vectors.
Inventor: Martin PULÉ
IPC: C07K16/00
Filed: 2016-03-01
Abstract: The present invention provides a retroviral or lentiviral vector having a viral envelope which comprises: (i) a mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain and a transmembrane domain; and/or (ii) a cytokine-based T-cell activating transmembrane protein which comprises a cytokine domain and a transmembrane domain, wherein the mitogenic or cytokine-based T-cell activating transmembrane protein is not part of a viral envelope glycoprotein. When cells such as T-cells of Natural Killer cells are transduced by such a viral vector, they are simultaneously activated by the mitogenic T-cell activating transmembrane protein and/or the cytokine-based T-cell activating transmembrane protein.
Patent MX-2017011170-A (MX)
Title: Peptides for inhibiting angiogenesis.
Inventor: YULIA A KOMAROVA
IPC: A61P27/00
Filed: 2016-03-02
Abstract: The present invention relates to peptides for inhibiting angiogenesis. The present invention also relates to methods of inhibiting angiogenesis and methods of treating disorders associated with VEGF-induced vascular permeability using the peptides of the invention.
Patent MX-2017012936-A (MX)
Title: Plant promoter for transgene expression.
Inventor: SANDEEP KUMAR
IPC: B62K1/00
Filed: 2016-04-13
Abstract: This disclosure concerns compositions and methods for promoting transcription of a nucleotide sequence in a plant or plant cell, employing a promoter from a Panicum virgatum metallothionein-like gene (mtl). Some embodiments relate to a promoter from a Panicum virgatum metallothionein-like gene (mtl) that functions in plants to promote transcription of operably linked nucleotide sequences.
Patent MX-2017013268-A (MX)
Title: Engine exhaust emissions treatment system.
Inventor: BRETT MAXWELL BAILEY
IPC: F01N13/00
Filed: 2016-04-11
Abstract: An engine system includes a compression ignition diesel engine connected with an aftertreatment system. A source of diesel fuel, which may have a high sulfur content, is fluidly connected to the engine. The aftertreatment system includes a particle trap fluidly positioned between the engine and the tailpipe, and an SCR catalyst fluidly positioned on the particle trap or between the particle trap and the engine. The SCR catalyst is a sulfur tolerant SCR catalyst. A non-thermal particle trap regeneration system includes a valve fluidly positioned between a particulate volume and an inlet to the particle trap. A reductant system has a doser positioned, possibly in the exhaust manifold, to deliver a reductant into the aftertreatment system upstream from the SCR catalyst.
Patent MX-2017016165-A (MX)
Title: Fast response heaters and associated control systems used in combination with metal treatment furnaces.
Inventor: ANDREW HOBBIS
IPC: C21D11/00
Filed: 2016-06-23
Abstract: System and method for using fast response heaters to pre-heat metal before entering a metal treatment furnace, which may improve control over metal processing, especially in response to changes in material, mass flow rate, line speed, and/or desired treatment process. Fast response heaters may be used with control systems to adjust the output of the fast response heater based on operator inputs, direct or indirect sensing of process parameters, and/or the use of thermal models to quickly adjust fast response heater output while a metal treatment furnace remains at a constant temperature or slowly transitions into a new operating state. The resulting gains in process control result in higher quality products, reduced scrap, and increases in line speed and output.
Patent MX-2017017069-A (MX)
Title: Radial configuration of a hybrid flow field (serpentine-interdigi ted) for collectors-diffusers of a fuel cell.
Inventor: Jose Luis LUVIANO ORTIZ
IPC: H01M8/02
Filed: 2017-12-20
Abstract: The present invention relates to a manifold-diffuser with a design of its flow field that uses the two most effective concepts for flow distribution: coil and interdigitated in a radial configuration. It has four inputs located in the corners of the flow field. Each of the entrances passes the species to a central flow distributor with interdigitated channels and a coil-shaped channel that has an outlet to the center of the collector-diffuser. It characterizes by possessing a low-pressure drop and a uniform distribution of species. Further, it is useful to distribute the fuel and/or the oxidant on the anode and cathode.
Patent MX-2018005146-A (MX)
Title: COMPOSITION STABLY CONTAINING SINGLE-STRANDED NUCLEIC ACID MOLECULE THAT SUPPRESSES EXPRESSION OF TGF-ß1 GENE.
Inventor: HIDEKAZU TOYOFUKU
IPC: C12N15/09
Filed: 2016-10-28
Abstract: The present invention provides a composition containing a buffer solution and a single-stranded nucleic acid molecule that comprises a nucleotide sequence represented by 5'-AGCAGAGUACACACAGCAUAUACC-P-GGUAUAUGCUGUGUGUACUCUGCUUC-P-G-3' (SEQ ID NO: 1) (in the sequence, P indicates a proline derivative linker represented by (I) in the specification), wherein the composition is characterized in that (a) the composition is in the form of a solution at normal temperature, and (b) the nucleic acid molecule content after the composition is stored for four weeks at 25°C and 60% RH is 80% or more relative to the nucleic acid molecule content at the start of storage.
Patent MX-2018005202-A (MX)
Title: Antibody to be cross-linked to human and mouse sema3a, and use thereof.
Inventor: DO HYUN NAM
IPC: A61K39/395
Filed: 2016-10-26
Abstract: The present invention provides an antibody having the ability to be cross-linked to human Sema3A and mouse Sema3A. The antibody of the present invention can be used as a therapeutic antibody for inhibiting Sema3A in various carcinomas in which Sema3A expression is high, such as glioblastoma, pancreatic cancer and liver cancer. Since Sema3A is considered to be a therapeutic target of diabetic retinopathy, autoimmune arthritis, neuropathic pain and osteoporosis, the antibody of the present invention or an antigen binding fragment thereof can be used as an agent, in addition to being used as an anticancer drug, for treating associated diseases. The antibody of the present invention inhibits the growth of cancer cells derived from various carcinomas, by using high anti-Sema3A binding and Sema3A function inhibition caused thereby, and inhibits the migration of cancer cells by inhibiting the phosphorylation of ERK among the downstream signaling materials of Sema3A, thereby being very effective in cancer prevention and treatment.
Patent MX-2018007672-A (MX)
Title: Low temperature cross linkable polychloroprene compositions.
Inventor: MARTIN SCHNEIDER
IPC: C08F36/18
Filed: 2016-11-25
Abstract: Essentially ethylene thiourea free cross linkable composition comprising a chloroprene rubber having defined contents of cations from the second or third main group and resinate anions are provided, which possess improved curing characteristics for increased productivity and lower vulcanization temperatures for energy-saving manufacturing methods and vulcanizates obtained by using said chloroprene rubber.
Patent MX-2018016007-A (MX)
Title: Stub shaft.
Inventor: SEAN M CARLINI
IPC: B60B35/00
Filed: 2018-12-18
Abstract: Apparatus and methods for achieving a high strength bonded joint between a stub connector and a shaft.
Patent MX-2019000593-A (MX)
Title: Automated smart water quality monitor and analyzer and associated methods.
Inventor: Meena SANKARAN
IPC: G01N33/18
Filed: 2017-07-13
Abstract: A fluid testing system can be used to measure the levels of contaminants in a fluid system. The system can utilize anodic stripping voltammetry or some other chemical, electrical, or electrochemical process to measure the contaminant levels. Wire electrodes may be used to facilitate the tests. Unused portions of the electrode wires can be fed into the test chambers between tests to ensure clean and reliable electrodes for subsequent testing.
Patent MX-2019002654-A (MX)
Title: Actuator assembly for electrical switches housed in an enclosure.
Inventor: Steven John TAAFFE
IPC: H01H3/04
Filed: 2017-09-06
Abstract: An actuator assembly for actuating electrical switches housed in an electrical enclosure is disclosed. The assembly includes at least one handle assembly including a handle positioned above a cover of the enclosure, a trip bracket positioned below the cover and a shaft connecting the handle to the trip bracket. At least one slider actuator is slidably mounted over the electrical switch and coupled to a toggle of the electrical switch. The slider actuator has a drive link which is adapted to be engaged with the trip bracket such that rotation of the handle causes the drive link to slide which in turn causes a linear movement of the slider actuator to toggle the electrical switch. The use of the slider actuator allows a higher density of electrical switches to be stacked inside the enclosure.
Patent MX-2019002766-A (MX)
Title: Method and apparatus for mitigating a fault in a distributed antenna system.
Inventor: IRWIN GERSZBERG
IPC: H04B10/038
Filed: 2017-09-08
Abstract: Aspects of the subject disclosure may include, for example, receiving a first wireless signal at a first carrier frequency, the first wireless signal including a first modulated signal generated by a second antenna system by frequency-shifting the first modulated signal from a first native frequency band to the first carrier frequency, receiving a second wireless signal at a second carrier frequency, the second wireless signal including a second modulated signal generated by a third antenna system by frequency-shifting the second modulated signal from a second native frequency band to the second carrier frequency, detecting a fault in the second antenna system, and responsive to the detecting, adjusting a power level of a first wireless transmission to generate an adjusted first wireless transmission directed to the third antenna system. Other embodiments are disclosed.
Patent MX-2019003140-A (MX)
Title: Configurable bop stack.
Inventor: VIRAL SHAH
IPC: E21B33/064
Filed: 2017-09-18
Abstract: The present disclosure is directed to systems and methods for a configurable blowout preventer (BOP) system for use in oil and gas operations. According to an embodiment, a BOP system can include two or more modular BOP ram cavity sets (1005-a, 1005-b, 1005-c), each of the BOP ram cavity sets having at least one BOP ram cavity (1013-a, 1013-b, 1013-c); one or more frame levels (1015-a, 1015-b), each of the frame levels separating each of the BOP ram cavity sets (1005-a, 1005-b, 1005-c) and coupling each of the BOP ram cavity sets (1005-a, 1005-b, 1005-c) together; and a plurality of hydraulic piping (1060-a, 1060-b, 1060-c, 1065-a, 1065-b, 1065-c) fluidly connected to each of the BOP ram cavity sets (1005-a, 1005-b, 1005-c), the plurality of hydraulic piping (1060-a, 1060-b, 1060-c, 1065-a, 1065-b, 1065-c) configured to drive operation of the BOP ram cavity sets (1005-a, 1005-b, 1005-c).
Patent MX-2019004404-A (MX)
Title: Concrete tiles and production process.
Inventor: DURAN BARRIOS GUILLERMO
IPC: E04F15/022
Filed: 2019-04-15
Abstract: The present invention relates to concrete tiles and the production process thereof. It comprises at least five stages consisting of the mixing process, adding the liquid components, plasticizer additive, water, and pigment, in a container or hopper (10) with a capacity of up 20kg to 30kg, beating the materials for a time of up to five minutes, adding the solid materials, hydraulic cement of high resistance, fine scratch, and coarse scratch. Also, it includes mixing for five minutes until forming a homogeneous consistency, preparing the molds (11) by applying canola oil made of polystyrene, Uranus, fiberglass, accommodating them on a rectangular vibrating table (12) to dislodge air bubbles and dispersing the mixture when starting the casting therein. Additionally, it comprises a setting or drying process using a single-phase electric oven (13) to remove moisture, removing the pieces for avoiding fractures or fissures, and checking quality and weight. The pieces are left to rest for 24 hours to reach a hardness of up 350 to 500 kg/cm2. The deburring stage eliminates any excess in the piece, going to the quality control and inspection area, making the separation thereof, for the final detail. Further, in the stage of applying a synthetic iron oxide coloring pigment for concrete to give it the programmed color, a first coat is applied to obtain the desired tone, allowing drying it for one hour. Finally, the stage of applying a silicone rubber sealant insolvent produces an invisible elastic layer that waterproofs and prevents absorption of moisture and ultraviolet rays. The application of a said sealant is left to dry for an hour, cleaned to remove the excess, concluding the finishing of the concrete tiles and performing its packaging.
Patent MX-2019007077-A (MX)
Title: Glp-1 receptor agonists and uses thereof.
Inventor: KENTARO FUTATSUGI
IPC: C07D471/04
Filed: 2017-12-01
Abstract: Provided herein are 6-carboxylic acids of benzimidazoles and 4-aza-, 5-aza-, 7-aza- and 4,7-diaza-benzimidazoles as GLP-1R agonists, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.
Patent MX-2019007335-A (MX)
Title: Methods of using thermostable serine proteases.
Inventor: STEPAN SHIPOVSKOV
IPC: A23J3/32
Filed: 2017-12-18
Abstract: Methods of using thermostable serine proteases are described herein.
Patent MX-2019010731-A (MX)
Title: Solvent deposition system and methods.
Inventor: Timothy Michael FULGHUM
IPC: A61L24/00
Filed: 2018-03-08
Abstract: A hemostatic device comprising a biomaterial matrix and a polymeric material prepared by combining the polymeric material with a solvent, applying the combination to the biomaterial, removing the solvent, and retaining an effective layer of the polymeric material to the biomaterial to enhance the performance of the hemostatic device in the treatment of wounds.
Patent MX-2019011120-A (MX)
Title: Nr wideband sync detection.
Inventor: ANDRES REIAL
IPC: H04J11/00
Filed: 2018-03-15
Abstract: A network sync signal with unknown frequency location is detected by sampling the received signal over a band of interest in frequency, and over the repetition period of the sync signal in time. The signal is converted to the frequency domain. Sub-bands of the frequency-domain signal, corresponding to different possible sync locations and frequency offsets, are extracted and converted to the time domain, where the sync signal is searched over the reception window length using time-domain matched filtering.
Patent MX-2019012803-A (MX)
Title: New bicyclic pyrazole derivatives.
Inventor: HANS-GEORG SCHWARZ
IPC: A61K31/429
Filed: 2018-04-23
Abstract: The present invention covers bicyclic pyrazole compounds of general formula (I) : in which G, A, R1, R2, R3, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
Patent MX-2019015322-A (MX)
Title: Hot-pressed member and method for manufacturing same, and cold-rolled steel sheet for hot pressing and method for manufacturing same.
Inventor: SEIJI NAKAJIMA
IPC: C22C38/60
Filed: 2018-03-30
Abstract: In the hot-pressed member according to the present invention, after the component composition thereof is properly adjusted, the microstructure thereof is configured so that the average grain size of prior austenite crystal grains is 7 µm or less at a depth 50 µm or less in a sheet thickness direction from the member surface, the volume fraction of martensite is 90% or greater, and the average inter-particle distance between carbonitrides of Nb and Ti having a grain size of less than 0.10 µm in a depth range of 20-100 µm from the member surface in the sheet thickness direction is 5 µm or less, whereby the hot-pressed member can have not only an extremely high tensile strength TS of 1780 MPa or greater after hot pressing, but can be provided with excellent indentation peel strength of a projection-welded part at the same time.
Patent MX-2020003270-A (MX)
Title: Combination of a btk inhibitor and an inhibitor of cdk9 to treat cancer.
Inventor: BOIKO SCOTT
IPC: A61K31/454
Filed: 2018-09-24
Abstract: The present invention relates to combination of a BTK inhibitor and an inhibitor of CDK9 for use in the treatment of cancer in a subject. The BTK inhibitor can be acalabrutinib, ibrutinib, or ONO/GS-4059; and the inhibitor of CDK9 can be AZD4573, BAY-1251152, BAY- 1143572, CYC065, alvocidib, AT7519, voruciclib, roniciclib, or dinaciclib.
Patent MX-2020003504-A (MX)
Inventor: ROBBINS PAUL F
IPC: C07K14/725
Filed: 2018-09-17
Abstract: Se describe un receptor de células T (TCR) aislado o purificado que tiene especificidad antigénica para p53 humano mutado. También se proporcionan polipéptidos y proteínas relacionadas, así como ácidos nucleicos, vectores de expresión recombinante, células hospedadoras, poblaciones de células y composiciones farmacéuticas relacionadas. También se describen métodos para detectar la presencia de cáncer en un mamífero y métodos para tratar o prevenir cáncer en un mamífero.
Patent MX-2020005274-A (MX)
Title: Writing gel ink.
Inventor: DEBRAUWER CHRISTELLE
IPC: C09D11/18
Filed: 2018-12-19
Abstract: The present invention concerns non-aqueous gel writing ink comprising a solvent, a coloring agent and a gelling agent, wherein the gelling agent is a mixture of silica particles and of a fatty acid amide wax. It also concerns the process of preparation of the non-aqueous gel writing ink and the use of a mixture of silica particles and of a fatty acid amide wax, as a gelling agent in a non-aqueous gel writing ink. It finally concerns a writing instrument containing the ink according to the present invention.
Patent MX-2020008584-A (MX)
Title: Atmospheric profiler.
Inventor: REYES DELGADO Luis Darío
IPC: G01N15/06
Filed: 2020-08-17
Abstract: The present invention relates to an atmospheric profiler for immediate visualization of the morphology of the atmospheric flow and the sequence of the spatial distribution of pollutants in real-time through its graphical interface and storing said information in your computer for further analysis. Said profiler allows analyzing a spatial plane of the atmosphere transporting pollutants by sensors distributed along with a mesh for detecting the physical characteristics of the flow that crosses said mesh by the sensors. Herein, the information is processed and analyzed by the program installed to display the results in the graphical interface.
Patent MX-2020009196-A (MX)
Title: Combination of lactobacilli for the relief of irritable bowel syndrome and for the relief of other gastrointestinal disorders.
Inventor: CARRIÈRE SERGE
IPC: A61P1/00
Filed: 2019-02-28
Abstract: Described herein are compositions and methods relating to the use of a combination of live lactobacilli bacteria, particularly live <i>Lactobacillus acidophilus</i>, live <i>Lactobacillus casei</i>, and live <i>Lactobacillus rhamnosus</i>, for the relief of undesirable gastrointestinal health problems such as irritable bowel syndrome (IBS), abdominal pain, abdominal discomfort, bloating, liquid stools and constipation. This combination of live lactobacilli bacteria can also be used for improving quality of life of a subject suffering from IBS, for the relief of IBS, and/or for the prevention and/or treatment of IBS.
Patent MX-2020010091-A (MX)
Title: Targeted thrombolysis for treatment of microvascular thrombosis.
Inventor: MAAS COEN
IPC: C07K14/00
Filed: 2019-03-27
Abstract: The present invention provides fusion proteins for targeted delivery of plasminogen activators to platelet-VWF complexes, or alternatively to the site where these are located, in a fibrin- independent manner. The fusion protein of the invention are for use in methods for the prevention or treatment of diseases or conditions associated with such platelet-VWF complexes, which may cause microvascular thrombosis in diseases such as e.g. thrombotic thrombocytopenic purpura. Preferred targeting agents for incorporation into the fusion proteins are e.g. nanobodies against VWF or platelets. Preferred plasminogen activators for use in the fusion proteins comprise the protease domains of uPA or tPA. The invention further pertains to nucleic acid molecule encoding the fusion proteins of the invention, e.g. a gene therapy vector, and to pharmaceutical compositions comprising the fusion proteins of the invention or such gene therapy vectors.
Patent MX-2020011263-A (MX)
Title: Methods and compositions of cytotoxic t cell depletion.
Inventor: STANKOVICH BASHA
IPC: C07K14/725
Filed: 2019-04-26
Abstract: The present application relates to compositions and methods for controlled cytotoxic T cell depletion, such as for the treatment of various diseases and conditions associated with cytotoxic T cells. The application provides engineered T cells comprising inter alia nucleic acids encoding an anti-cytotoxic T lymphocyte (CTL) protein capable of conferring to the engineered T cell cytotoxicity towards a CTL. The anti-CTL protein may comprise an extracellular BETA2-microglobulin domain.
Patent MX-2020011506-A (MX)
Title: Treatment of metabolic disorders in equine animals.
Inventor: REICHE DANIA BIRTE
IPC: A61P19/00
Filed: 2016-09-28
Abstract: The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.